An Official Website of the United States Government
Company Information:
Name:
IFYBER, LLC
Address:
950 DANBY RD
ITHACA, NY
ITHACA, NY
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(607) 227-8983
Award Totals:
Award List:
Nanoparticle-based Wound Care for Antibiotic Resistant Pathogens
Award Year / Program / Phase:
2009 / STTR / Phase I
Agency / Branch:
DOD / NAVY
Research Institution:
University at Albany - SUNY
Principal Investigator:
Aaron Strickland, Director of R&D
Award Amount:
$69,999.00
RI Contact:
Nathaniel Cady
Abstract:
This proof-of-concept research effort will lay the foundation for integrating metal nanoparticle-coated natural fibers into antibacterial wound dressings and sutures. A current military need for the proposed technology is in the arena of topical preventative measures against and treatments for… More
Transparent Polymeric-Zinc Oxide Coatings for Highly Conductive Cotton
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency / Branch:
DOD / USAF
Principal Investigator:
Aaron D. Strickland, VP
Award Amount:
$99,999.00
Abstract:
This proof-of-concept research effort will lay the foundation for integrating conductive natural fibers into garments for point-of-failure sensing. A current military need for the proposed technology is in the arena of chemical and biological (CB) agent protective garments where a sensor that can… More
Integrated Textile Detection Platform for Positive Identification
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
Aaron D. Strickland, DPhil
Award Amount:
$150,000.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project aims to develop a novel textile coating and reading device for positive identification applications such as anti-counterfeit, textile brand verification, etc. The basis of this project is to use a layer-by-layer self-assembly process to… More
SBIR Phase I: Nanoparticle Antimicrobial Coatings on Natural Scaffolds for Tissue Reconstruction
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
Aaron D. Strickland
Award Amount:
$150,000.00
Abstract:
This Small Business Innovation Research Phase I project addresses the important problem of combating hospital acquired infections with the development of novel tissue matrices aimed at preventing nosocomial microbial infection. The aim of this project is to combine antimicrobial nanomaterials and a… More
Lab-on-a-Bubble: A powerful, low-cost, point-of-care diagnostic platform technology
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
DOD
Principal Investigator:
Aaron Strickland, Vice President Research-Development – (607) 227-7522
Award Amount:
$100,000.00
Abstract:
iFyber LLC proposal define a novel solution for the Point-of-Care diagnostics market. Traditional In-Vitro Diagnostic testing most often requires multiple steps (sample purification and analyte separation, analyte concentration/amplification, and detection) to achieve even qualitative levels of… More
KINETICALLY CONTROLLABLE, THERAPEUTIC TOPICAL DELIVERY OF NITRIC OXIDE THROUGH NOVEL BIODEGRADABLE"PSEUDO-PROTEIN"BIOMATERIALS
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
DOD
Principal Investigator:
Aaron D. Strickland, VP, Research and Development – (607) 227-7522
Award Amount:
$69,900.00
Abstract:
iFyber LLC, the lead company for this project, will partner with Prof. CC Chu from Cornell University, a recognized expert in the development and study of new drug-eluting biomaterials for wound healing, to develop a platform technology for controlled release of nitric using a newly invented family… More
A new class of biodegradable synthetic biomaterial for seroma prevention
Award Year / Program / Phase:
2012 / STTR / Phase I
Agency:
HHS
Research Institution:
CORNELL UNIVERSITY
Abstract:
DESCRIPTION (provided by applicant): Seromas are a common post-operative complication particularly prevalent following ablative and reconstructive surgeries. Without timely intervention post-operative seromas can lead to significant patient morbidity including infection, tissue necrosis, permanent… More